Adamowicz Jan, Tworkiewicz Jakub, Siekiera Jerzy, Drewa Tomasz
Department Tissue Engineering, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
Contemp Oncol (Pozn). 2013;17(1):24-8. doi: 10.5114/wo.2013.33770. Epub 2013 Mar 15.
Ablative therapies of renal tumors are steadily gaining popularity in clinical practice due to the many benefits they offer to patients. Moreover, ablative procedures hold promise in the field of uro-oncology for the best compromise between low invasiveness, high efficacy and advantages in terms of procedural costs. Reported outcomes with ablative therapies for small renal tumors are excellent and without significant differences for surgical procedures based on nephron-sparing surgery. Nevertheless, these methods for treatment of small renal tumors should still be confined to carefully selected patients. This review discusses the currently used ablative techniques in urology.
由于肾肿瘤消融治疗为患者带来诸多益处，其在临床实践中越来越受到欢迎。此外，消融手术在泌尿肿瘤学领域有望在低侵袭性、高疗效和手术成本优势之间实现最佳平衡。小肾肿瘤消融治疗的报告结果良好，与基于保留肾单位手术的外科手术相比无显著差异。然而，这些小肾肿瘤的治疗方法仍应局限于精心挑选的患者。本文综述了目前泌尿外科中使用的消融技术。
